More News

01 Jun 2023 Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics Ltd
01 Jun 2023 LTZ Announces over $10 Million Pre-A+ Financing to Advance Development of its Immunotherapy Pipeline to Treat Cancer and Autoimmune Diseases
25 May 2023 HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease
25 May 2023 Novo Nordisk and Life Edit Therapeutics Establish Multi-Target Collaboration to Discover and Develop Gene Editing Therapies for Rare and Cardiometabolic Diseases
24 May 2023 Pyxis Oncology to Acquire Apexigen
24 May 2023 Pathos Launches Precision Oncology Pipeline With License of First Phase I Program, a CBP/p300 Inhibitor
23 May 2023 Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases
23 May 2023 AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
18 May 2023 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) launches Luzsana Biotechnology™ (Luzsana)
17 May 2023 Chinook Therapeutics Announces Partnership with Ionis to Develop Antisense Therapy for Rare, Severe Chronic Kidney Disease
15 May 2023 Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis English
10 May 2023 Amgen and TScan Therapeutics announce collaboration to identify novel targets in Crohn's disease
10 May 2023 Sobi to Acquire CTI BioPharma
10 May 2023 Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera
09 May 2023 Neuro3 Therapeutics Acquires Exclusive Worldwide Rights to Develop and Commercialize Clinical Stage KCNQ2 Activators from Lundbeck
04 May 2023 Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines
02 May 2023 Maze Therapeutics Announces Exclusive Worldwide License Agreement with Sanofi for MZE001, an Oral Substrate Reduction Therapy for the Treatment of Pompe Disease
01 May 2023 Astellas Enters Into Definitive Agreement to Acquire Iveric Bio
27 Apr 2023 ITM Enters Cooperation Agreement with Paul Scherrer Institute (PSI) for Co-Development and Upscaled Manufacturing of Terbium-161 for Theranostic Application in Cancer
25 Apr 2023 4DMT Acquires Complement Pathway Inhibitor Payload for 4D-175 Product Candidate for Geographic Atrophy
21 Apr 2023 Oncoinvent Announces Two Publications in Special Edition of Frontiers in Medicine Focused on Alpha Radioisotopes
18 Apr 2023 Coeptis Therapeutics Signs Agreement to Acquire Allogeneic Immuno-Oncology NK Platform in Phase 1 Clinical Trials from Deverra Therapeutics
18 Apr 2023 GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
17 Apr 2023 Genmab and argenx Enter Partnership to Advance Antibody Therapies in Immunology and Oncology
17 Apr 2023 Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up